Danaher Schedules Second Quarter 2019 Earnings Conference Call

WASHINGTON, June 18, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2019 on Thursday, July 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

QIAGEN to deliver genomic insights for Japan’s new molecular oncology clinical research and precision medicine initiative

Hilden, Germany, and Tokyo, Japan, June 18, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QIAGEN Clinical Insight (QCI) offering was selected by the National Cancer Center of Japan, as part of the Japan’s Ministry of Health, Labour and Welfare’s precision medicine program, for the analysis, interpretation and reporting of molecular... Read more

Ontera Awarded ~$1M Contract from IARPA for Zika Genotyping Test

June 18, 2019 07:30 AM Eastern Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Ontera Inc., the leader in silicon-based nanopore diagnostics, announced today that the company has received a $982,593 contract from Intelligence Advanced Research Projects Activity (IARPA), part of the Office of the Director of National Intelligence that invests in research and innovative technologies to strengthen... Read more

Thermo Fisher Scientific Launches Powerful Invitrogen iBright 1500 Imaging System Series for Western Blot and Gel Imaging

Thermo Fisher Scientific Launches Powerful Invitrogen iBright 1500 Imaging System Series for Western Blot and Gel Imaging Featuring advanced time saving technology and intuitive user interface, designed to accelerate science CARLSBAD, Calif., June 17, 2019 /PRNewswire/ — For biological researchers requiring high-quality images from their samples without over-investing time and resources, a new, easy-to-use imaging platform... Read more

QIAGEN launches novel NGS panel for rare and inherited diseases with advanced bioinformatics for complete Sample to Insight solution

Hilden, Germany, and Germantown, Maryland, June 14, 2019 – QIAGEN today announced the launch of a novel Sample to Insight solution for translational and clinical research into genetic drivers of rare and inherited diseases. The new QIAseq Expanded Carrier Screening Panel provides identification of targets, genes and other regions of interest responsible for more than 200... Read more

At ESHG 2019 Paragon Genomics Presents Data Highlighting Accuracy, Scalability and Speed of CleanPlex® Target Enrichment Technology and Introduces CleanPlex Products for MGI Sequencers

— Two CleanPlex® Ready-to-Use and CleanPlex Custom NGS Panels Now Available for MGI Sequencers — Partner MGI Hosting Satellite Session that Includes Discussion of CleanPlex Panels for MGI Products — Partner Sophia Genetics Hosting Satellite Session Discussing Use of CleanPlex Custom NGS Panel with SOPHiA Genomic Analysis Platform for Rapid Profiling of Hereditary Disease Variants — ESHG Posters Show... Read more

Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants

MENLO PARK, Calif., June 13, 2019 (GLOBE NEWSWIRE) — While DNA sequencing tools have been useful for determining the genetic cause of many diseases, there remain a large number that are left unexplained. Recently, scientists have adopted Single Molecule, Real-Time (SMRT®) Sequencing from Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing... Read more

Saphetor SA and Swift Biosciences Announce Partnership to Standardize and Accelerate Data Interpretation for Targeted NGS Panels

Lausanne, June 12th, 2019 Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.... Read more